Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Interim phase I/II data suggest safety of everolimus in advanced HCC

Sep. 27, 2010

First selective Aurora kinase A inhibitors identified

Sep. 23, 2010

Peretinoin shows potential as first-line agent to prevent recurrence of HCC

Sep. 22, 2010

Hybrigenics reports phase IIa data on inecalcitol/docetaxel combination in prostate cancer

Sep. 21, 2010

Boehringer Ingelheim begins phase III afatinib trial in breast cancer

Sep. 21, 2010

Daiichi Sankyo identifies new inhibitors of HSP 90 ATPase activity

Sep. 21, 2010

Phase II trial begins for SG-2000 in ovarian cancer

Sep. 20, 2010

Urifer claims new heterocyclic compound for cancer therapy

Sep. 20, 2010

Enrollment of first cohort complete in phase I trial of PV-10 for liver cancer

Sep. 17, 2010

Banyu Pharma identifies new inhibitors of wee1-like protein kinase

Sep. 17, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...